News

Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...

Plymouth, MA – November 12, 2024 – MitoSense Inc., a leader in mitochondria lresearch and innovation, proudly announces the publication...

September 6, 2024 – Tampa, FL  – MitoSense, holder of an exclusive license on groundbreaking technology from the Elliott Mitochondria...

MitoSense, Inc. is proud to announce its participation in the 2024 Military Health System Research Symposium (MHSRS), taking place August...

We are thrilled to announce that MitoSense Inc. has been accepted into the prestigious NVIDIA Inception Program! This milestone marks a...

MitoSense's Chief Medical Officer, Dr. Catherine Baucom, has been invited to provide a Statement for the Record for the U.S. House of...

SOURCE: Hop On A Cure ATLANTA, Ga. (January 30, 2024) - Nonprofit foundation Hop On A Cure, a leading advocate in the fight against ALS,...

PLYMOUTH, Mass., Jan. 25, 2024 /PRNewswire/ -- MitoSense Inc., a leading innovator in biotechnology with a focus on neurodegenerative...